12:00 AM
Jul 27, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

FST-100: Pilot trial data

In an open-label, U.S. pilot trial, FST100 4 times/day for 5 days met the primary endpoint of complete resolution of conjunctival injection and conjunctival discharge in all eyes that completed the study....

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >